TY - JOUR
T1 - The polyphenolics in the aqueous extract of Psidium guajava kinetically reveal an inhibition model on LDL glycation
AU - Chen, Kuan Chou
AU - Chuang, Chao Ming
AU - Lin, Li Yun
AU - Chiu, Wen Ta
AU - Wang, Hui Er
AU - Hsieh, Chiu Lan
AU - Tsai, Tsui Min
AU - Peng, Robert Y.
PY - 2010/1
Y1 - 2010/1
N2 - Guava [Psidium guajava L. (Myrtaceae)] budding leaf extract (PE) has shown tremendous bioactivities. Previously, we found seven major compounds in PE, i.e., gallic acid, catechin, epicatechin, rutin, quercetin, naringenin, and kaempferol. PE showed a potentially active antiglycative effect in an LDL (low density lipoprotein) mimic biomodel, which can be attributed to its large content of polyphenolics. The glycation and antiglycative reactions showed characteristic distinct four-phase kinetic patterns. In the presence of PE, the kinetic coefficients were 0.000438, 0.000060, 0.000, and -0.0001354 ABS-mL/mg-min, respectively, for phases 1 to 4. Computer simulation evidenced the dose-dependent inhibition model. Conclusively, PE contains a large amount of polyphenolics, whose antiglycative bioactivity fits the inhibition model.
AB - Guava [Psidium guajava L. (Myrtaceae)] budding leaf extract (PE) has shown tremendous bioactivities. Previously, we found seven major compounds in PE, i.e., gallic acid, catechin, epicatechin, rutin, quercetin, naringenin, and kaempferol. PE showed a potentially active antiglycative effect in an LDL (low density lipoprotein) mimic biomodel, which can be attributed to its large content of polyphenolics. The glycation and antiglycative reactions showed characteristic distinct four-phase kinetic patterns. In the presence of PE, the kinetic coefficients were 0.000438, 0.000060, 0.000, and -0.0001354 ABS-mL/mg-min, respectively, for phases 1 to 4. Computer simulation evidenced the dose-dependent inhibition model. Conclusively, PE contains a large amount of polyphenolics, whose antiglycative bioactivity fits the inhibition model.
KW - Antiglycation
KW - LDL glycation
KW - Psidium guajava L.
UR - http://www.scopus.com/inward/record.url?scp=73949141756&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=73949141756&partnerID=8YFLogxK
U2 - 10.3109/13880200903029365
DO - 10.3109/13880200903029365
M3 - Article
C2 - 20645752
AN - SCOPUS:73949141756
SN - 1388-0209
VL - 48
SP - 23
EP - 31
JO - Pharmaceutical Biology
JF - Pharmaceutical Biology
IS - 1
ER -